7th Edition of Neurology World Conference 2027

For many people, a headache isn't a passing problem. It can mean a missed shift, a canceled plan, or a whole weekend spent in a dark room. Add the millions living with nerve pain or facial pain, and it becomes clear why these conditions are among the biggest drivers of disability around the world. Too often, patients try one treatment after another before they find something that truly works.

This track looks at how that is starting to change. We will discuss migraine in all its forms, along with cluster headache, tension-type headache, trigeminal neuralgia, and neuropathic pain. Speakers will share where CGRP antibodies and gepants fit into everyday practice today, what early studies of PACAP-targeted drugs are showing, and when nerve blocks or neuromodulation devices make sense for patients who have not responded to medicines. We will also ask an important question: why does short-term pain sometimes turn into a long-term condition, and can that process be stopped?

Neurologists, pain specialists, researchers, nurses, and therapists are all welcome. Bring your data, your difficult cases, and your questions, and help shape better care for people who live with pain every day.

Topics include:

• New options for treating and preventing migraine
• CGRP and PACAP-based treatments
• Cluster headache and other trigeminal autonomic cephalalgias
• Trigeminal neuralgia and other facial pain conditions
• Understanding and treating neuropathic pain
• Medication-overuse and post-traumatic headache
• Nerve blocks and neurostimulation techniques
• How pain becomes chronic: central sensitization explained

Be part of the conversation that is moving headache and pain medicine forward.